Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.22 |
---|---|
High | 3.22 |
Low | 3.22 |
Bid | 3.26 |
Offer | 3.30 |
Previous close | 3.38 |
Average volume | 0.00 |
---|---|
Shares outstanding | 160.03m |
Free float | 157.33m |
P/E (TTM) | -- |
Market cap | 534.49m USD |
EPS (TTM) | -0.016 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:02 GMT.
More ▼
Press releases
- Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
- Ironwood Pharmaceuticals Reports Third Quarter 2024 Results
- Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024
- Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call
- Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
More ▼